TítuloSerum levels of the adipomyokine irisin in patients with chronic kidney disease

Liabeuf et al., “Serum indoxyl sul- fate is associated with vascular disease and mortality in chronic kidney disease patients,” Clinical Journal of the American Society of

The 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults defines hypertension as an office systolic BP 130 or an

 CMOS sensors offer large format, high frame rate, and low read noise.. Silicon detectors need to get larger as telescopes increase

2.2.2 In RA patients without (1) established CVD, (2) diabetes, (3) moderate or severe chronic kidney disease, or (4) severe dyslipidemia, we suggest refining CVD risk assessment

The patients with ADPKD included in the study had worse renal function (worse mean estimated by glomerular filtration rate [eGFR], more in patients with CKD stage 4) and

Changes in serum IL-15 levels at 4 and 8 weeks as compared with baseline values were directly associated with changes in body weight, BMI, fat-free mass, and muscle mass

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE), Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney

A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk